Skip to main content
Clinical Trials/NL-OMON53178
NL-OMON53178Not yet recruitingNot Applicable

Stress-induced immune reprogramming in cardiovascular disease (STRESS-CVD) - STRESS-CVD

niversitair Medisch Centrum0 sites125 target enrollmentStarted: TBDLast updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Not yet recruiting
Sponsor
Enrollment
125

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Observational

Eligibility Criteria

Ages
18 to 99 (—)

Inclusion Criteria

  • In order to be eligible to participate in this study, a subject must meet all
  • of the following criteria:
  • - Age 40-70 years
  • - Heightened cardiovascular risk, defined as a moderate to high risk for CVD
  • (>7.5% 10 year ASCVD risk, according to American College of Cardiology (ACC)
  • AtheroSclerotic Cardiovascular Disease (ASCVD) risk calculator
  • (https://tools.acc.org/ASCVD-Risk-Estimator-Plus/#!/calculate/estimate/) or
  • patients with subclinical ASCVD on imaging (e.g. elevated CAC or asymptomatic
  • coronary artery stenosis).
  • - Written informed consent

Exclusion Criteria

  • A potential subject who meets any of the following criteria will be excluded
  • from participation in this study:
  • Previous cardiovascular events (stroke, TIA, myocardial infarction)
  • Heart failure
  • Auto-inflammatory or auto-immune diseases
  • Use of immunomodulating drugs
  • Severe renal failure (MDRD <30)
  • Previous vaccination within 1 months prior to study entry.
  • Current infection or clinically significant infections within 1 months before
  • participation (defined as fever >38.5).
  • Pregnancy/lactation
  • Severe psychiatric disorder.
  • Inability to undergo PET-CT scanning
  • History of hematological malignant disease
  • Documented bleeding diathesis or thrombocytopenia <50 *10e9/L

Investigators

Sponsor
niversitair Medisch Centrum

Similar Trials